Burns E R
Am J Anat. 1987 Jul;179(3):308-13. doi: 10.1002/aja.1001790312.
The objective of this experiment was to attempt to induce, with hydroxyurea (HU), significant quantitative differences in the level of DNA-synthetic activity (DNA-SA) between a neoplastic cell population (the Ehrlich ascites carcinoma or EAC) and bone marrow in the same animal. Mice bearing a 5-day-old EAC were standardized to and kept on an LD 12:12 cycle (light 0600-1800 hr). They were treated with 500 mg/kg HU at 0500 hr (23 hr after lights on, or HALO) or at 1700 hr (11 HALO). DNA-SA was determined by liquid scintillation counting of 3H-thymidine incorporation into chemically isolated DNA. DNA-SA in bone marrow and EAC cells was monitored over the next 60 hr with subgroups of ten mice each killed every 3 hr beginning 3 hr after treatment with HU. The circadian system of the host influenced the response of the bone marrow to HU; i.e., the response to HU administered at 0500 hr was different both qualitatively and quantitatively from that for HU given at 1700 hr. Comparisons of DNA-SA in bone marrow and EAC from the same animal revealed time points after treatment with HU when DNA-SA in the EAC was high, but DNA-SA in bone marrow was low. These differences in the level of DNA-SA between a tumor cell population and bone marrow should be of therapeutic value; i.e., executor doses of anti-DNA-SA drugs such as cytosine arabinoside could be given at that point in time after treatment with HU when DNA-SA in the tumor was high, but DNA-SA in the bone marrow was low.
本实验的目的是尝试用羟基脲(HU)在同一动物的肿瘤细胞群体(艾氏腹水癌或EAC)和骨髓之间诱导出DNA合成活性(DNA-SA)水平上显著的定量差异。携带5日龄EAC的小鼠被标准化并维持在12:12的明暗周期(光照时间为06:00-18:00)。它们在05:00(开灯后23小时,即HALO)或17:00(11 HALO)接受500 mg/kg的HU处理。DNA-SA通过对化学分离的DNA中3H-胸腺嘧啶掺入量进行液体闪烁计数来测定。在接下来的60小时内监测骨髓和EAC细胞中的DNA-SA,从用HU处理后3小时开始,每3小时处死每组10只小鼠的亚组。宿主的昼夜节律系统影响骨髓对HU的反应;也就是说,在05:00给予HU的反应在质量和数量上都与17:00给予HU的反应不同。对同一动物骨髓和EAC中DNA-SA的比较显示,在用HU处理后的时间点,EAC中的DNA-SA较高,但骨髓中的DNA-SA较低。肿瘤细胞群体和骨髓之间DNA-SA水平的这些差异应具有治疗价值;即,在肿瘤中的DNA-SA较高但骨髓中的DNA-SA较低时,在用HU处理后的那个时间点可以给予抗DNA-SA药物如阿糖胞苷的执行剂量。